Skip to main content
SpringerLink
Log in

Biologika zur Therapie der eosinophilen Granulomatose mit Polyangiitis

Churg-Strauss-Syndrom: Benralizumab so effektiv wie Mepolizumab?

  • Journalclub
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. White J, Dubey S. Eosinophilic granulomatosis with polyangiitis: A review. Autoimmun Rev. 2023;22(1):103219

  2. Gillissen A. Biologika in der Asthmatherapie - was gibt es, was kommt? Pneumo News. 2022;14:27-34

  3. Gillissen A. Biologika in der Asthma-Therapie: Welche Präparate gibt es? Hausarzt. 2023;11:46-55

  4. Wechsler ME, Akuthota P, Jayne D et al. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis. N Engl J Med. 2017;376:1921-32

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik III, Kreiskliniken Reutlingen, Steinenbergstraße 31, 72764, Reutlingen, Deutschland

    Adrian Gillissen

Authors
  1. Adrian Gillissen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adrian Gillissen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gillissen, A. Churg-Strauss-Syndrom: Benralizumab so effektiv wie Mepolizumab?. Pneumo News 16, 15–16 (2024). https://doi.org/10.1007/s15033-024-3988-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-024-3988-8

Search

Navigation